Evidence map›Paper›PMID 40728969›Full record

ReviewCurrent issues in molecular biology2025

The Role of Vitamin D and Vitamin D Receptor in Sepsis.

Shenglan Shang, Dongxin Chen, Yuqi Wei, Shuo Zou, Qiuyue Chang, Hong Zhou, Airong Yu

Abstract readReview
In one paragraph

Review in Current issues in molecular biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Vitamin D3 contribution to systemic and local control ofFrontiers in molecular biosciences · 2026
    Article
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shenglan ShangDepartment of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430070, China.ORCID 0000-0002-2771-6100
Dongxin ChenDepartment of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430070, China.
Yuqi WeiDepartment of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430070, China.
Shuo ZouDepartment of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430070, China.
Qiuyue ChangDepartment of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430070, China.
Hong ZhouKey Laboratory of Basic Pharmacology of Ministry of Education and Joint International Research Laboratory of Ethnomedicine of Ministry of Education, Zunyi Medical University, Zunyi 563006, China.
Airong YuDepartment of Clinical Pharmacy, General Hospital of Central Theater Command, Wuhan 430070, China.

Funding

China Postdoctoral Science Foundation 2022M713859Knowledge Innovation Project of Wuhan city 2022020801020521National Natural Science Foundation of China 82304576Nature Science Foundation of Hubei Province 2022CFB879Open Foundation of Hubei Key Laboratory of Central Nervous System Tumor and Intervention ZZYKF202304
6 · The paper itself

Abstract

Sepsis acts as the leading cause of mortality in intensive care units, characterized by life-threatening organ dysfunction due to a dysregulated host response to infection. Vitamin D (VD) pleiotropic functions were demonstrated in different biological processes, including inflammation and immunity. VD receptor (VDR) is a member of the nuclear receptor superfamily, involved in immunoregulation and resistance to infections. Previous studies have demonstrated that VD deficiency is a potential risk factor for sepsis development, which may be regulated by VDR-related physiological processes. In this review, we present a comprehensive overview of the roles of VD and VDR in sepsis, focusing on immune modulation, anti-inflammatory and anti-infective responses, oxidative stress regulation, gut microbiome enhancement, vascular endothelial cell modulation, and antiplatelet activity. We also discuss recent advances in clinical research on VD/VDR in sepsis, considering the clinical implications and potential interventions of VD analogs and VDR ligands in treatment. Despite its challenges, VD holds potential for personalized sepsis interventions. Additionally, VD/VDR may serve as a promising bidirectional immunomodulator, capable of addressing both hyperinflammatory and immunosuppressive phases of sepsis, yet require systematic investigations into its dynamic states and functions across different sepsis phases. Ongoing study and evidence-based guidelines are crucial to maximize its therapeutic benefits and improve clinical outcomes.

Indexed as

anti-inflammationimmunomodulationsepsisvitamin Dvitamin D receptor

Identifiers

PMID40728969
PMCPMC12293739

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.